Peptide
Humanin
24-amino-acid mitochondrial peptide described as neuroprotective against oxidative stress and linked to the regulation of IGF-1. No human trials.
Sources
Our own summaries · Cited studies
Recommended dose and how to use
No human regimen. Preclinical research only.
Regulatory status
Not approved
FDA (U.S.): Not approved (preclinical and observational research only).
EMA (EU): Not approved.
How to take it
No human regimen. Preclinical research only.
Safety
Zero human trials. Safety and efficacy undetermined.
Effect by goal · level of evidence
improves Low review (A)
In vitro only
2023 review: humanin and its analogs protect neurons from oxidative stress and Alzheimer-type toxicity in cells and animals. There are no clinical data.
View the study (review) →Information, not medical advice. Scientific evidence reflects the quality of the studies.